Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merus NV

45.51
+0.46001.02%
Post-market: 45.510.00000.00%16:05 EDT
Volume:307.69K
Turnover:13.98M
Market Cap:3.14B
PE:-13.57
High:45.80
Open:44.64
Low:44.38
Close:45.05
Loading ...

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Walgreens Boots Alliance (WBA) and Merus (MRUS)

TIPRANKS
·
24 Apr

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting

GlobeNewswire
·
23 Apr

Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now?

Insider Monkey
·
18 Apr

Analysts’ Top Healthcare Picks: Merus (MRUS), Corcept Therapeutics (CORT)

TIPRANKS
·
17 Apr

Strength Seen in BioMarin (BMRN): Can Its 6.3% Jump Turn into More Strength?

Zacks
·
10 Apr

Merus Is Maintained at Buy by Needham

Dow Jones
·
09 Apr

Merus Price Target Maintained With a $109.00/Share by Guggenheim

Dow Jones
·
28 Mar

Merus Price Target Maintained With a $109.00/Share by Guggenheim

Dow Jones
·
18 Mar

Merus Is Maintained at Buy by B of A Securities

Dow Jones
·
11 Mar

Stifel Nicolaus Sticks to Its Buy Rating for Merus (MRUS)

TIPRANKS
·
06 Mar

Merus Price Target Maintained With a $85.00/Share by HC Wainwright & Co.

Dow Jones
·
03 Mar

Merus Is Maintained at Buy by Needham

Dow Jones
·
28 Feb

Truist Financial Sticks to Their Buy Rating for Merus (MRUS)

TIPRANKS
·
28 Feb

Merus Nv : Bmo Raises Target Price to $96 From $95

THOMSON REUTERS
·
28 Feb

Merus NV reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Merus N.V. (MRUS) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
28 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Merus (MRUS) and Ramsay Health Care (OtherRMSYF)

TIPRANKS
·
28 Feb

Merus FY 2024 GAAP EPS $(3.35) Beats $(3.80) Estimate, Sales $36.133 Miss $38.544M Estimate

Benzinga
·
28 Feb

Merus NV Based On Co's Current Operating Plan, Existing Cash, Cash Equivalents And Marketable Securities Expected To Fund Merus' Operations Into 2028

Reuters
·
28 Feb

Merus to Present at Upcoming Investor Conferences

GlobeNewswire
·
25 Feb